QYUNS-B

2509
14.4002.04% ( -0.300 )
Delay Closed: Nov 16, 16:08:11

Overview

QYUNS-B (2509)

Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseas...

Open
14.420
High
14.560
Low
14.400
Prev. Close
14.700
Volume
30.00K
Turnover
432.42K
Avg Price
14.414
Bid/Ask Ratio
77.78%
Amplitude
1.09%
52wk High
24.500
Volume Ratio
0.28
Turnover Ratio
0.01%
52wk Low
13.210
HK Mkt Cap
3.22B
Market CapHKD
3.22B
P/ETTM
5.12
P/EDynamic
6.87
P/EStatic
--
EPSTTM
2.81
EPSDynamic
2.10
EPSStatic
--
BVPS
4.44
P/B
3.24
HK Shares
223.37M
Dividend YieldTTM
--
DividendTTM
--
Shares
223.37M
Min lot size
200
Currency
HKD

QYUNS-B Analyst Rating

View more

Forecast & Rating

Sep 21, 2026
Price forecast
HK$33.00129.17%
Forecast & RatingBuy
2analysts
  • Strong buy50.00%
  • Buy50.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    Qyuns Therapeutics closed up 3.84% at HKD 15.40 today, opening low and rallying to an intraday high of HKD 15.87, up over 7% from the previous close of HKD 14.83. Total turnover was approximately HKD 1.62 million with a turnover rate of 0.05%. Recent share buybacks at HKD 13.4-13.99, coupled with strong Q4 2025 results showing a 451% YoY revenue jump to HKD 334 million and a net profit of HKD 191 million (up 319% YoY), underpinned the rally. However, the stock remains 57.81% below its 52-week high of HKD 36.50 and below the 60-day MA of HKD 16.88, with a YTD decline of 21.35%.

News